Therapeutic compounds and compositions
OwnerBertrand L. Chenard, Yuelian Xu +2inventors
InventorsBertrand L. Chenard, Yuelian Xu, Frans L. Stassen, Neil J. Hayward
Life of this patent
Estimating the term…
Abstract
The present invention provides compounds that inhibit Factor XIa or kallikrein and pharmaceutically acceptable salts thereof and compositions thereof. The present invention also provides methods of using these compounds and compositions.
Claims36
A compound of formula (I-1):
- or a pharmaceutically acceptable salt thereof, wherein
- R1 is hydrogen or —NR8R9;
- Ra is C1-6 alkyl, C1-6 haloalkyl, halo, cyano, or —OR6;
- Rb is hydrogen or C1-6 alkyl;
- R2 is C1-6 alkyl, C1-6 haloalkyl, cycloalkyl, heterocyclyl, aryl, heteroaryl, or —OR6, wherein the cycloalkyl, heterocyclyl, aryl, or heteroaryl is optionally substituted with one, two, or three independent occurrences of halo, C1-6 alkyl, C1-6 haloalkyl, or —OR6;
- R3 is hydrogen, C1-6 alkyl, or C1-6 haloalkyl, or
- R2 and R3, taken together with the nitrogen atom to which they are attached form a ring (e.g., a 3-10 membered ring);
- R4 is C1-6 alkyl, C1-6 haloalkyl, cycloalkyl, heterocyclyl, aryl, or heteroaryl, wherein the cycloalkyl, heterocyclyl, aryl, or heteroaryl is optionally substituted with one, two, or three independent occurrences of halo, C1-6 alkyl, C1-6 haloalkyl, cyano, or —OR6;
- R5 is hydrogen, C1-6 alkyl, C1-6 haloalkyl, cycloalkyl, or aryl, wherein the cycloalkyl or aryl is optionally substituted with one, two, or three independent occurrences of halo, C1-6 alkyl, C1-6 haloalkyl, or —OR6 or
- R4 and R5, taken together with the carbon atom to which they are attached form a ring;
- R6 is hydrogen, C1-6 alkyl, or C1-6 haloalkyl;
- each R8 and R9 is independently hydrogen C1-6 alkyl, —C(O)R10, or —C(O)OR10;
- R10 is C1-6 alkyl or C1-6 haloalkyl;
- m is 0, 1, 2, or, 3;
- and
- n is 0 or 1, wherein if n is 0, then R5 is hydrogen and R4 is absent.
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
12-14. (canceled)
(canceled)
(canceled)
19-22. (canceled)
24-27. (canceled)
29-31. (canceled)
A compound of the formula:
(canceled)
36-60. (canceled)
62-64. (canceled)
67-128. (canceled)
131-134. (canceled)
A pharmaceutically acceptable salt of a compound of the formula:
Dependencies are inferred from the claim text.